Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis

被引:60
作者
Breedveld, FC [1 ]
Han, C
Bala, M
van der Heijde, D
Baker, D
Kavanaugh, AF
Maini, RN
Lipsky, PE
机构
[1] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[2] Centocor Inc, Outcomes Res, Malvern, PA 19355 USA
[3] Univ Hosp Maastricht, Dept Internal Med Rheumatol, Maastricht, Netherlands
[4] Centocor Inc, Clin Res & Dev, Malvern, PA USA
[5] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[6] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London, England
[7] NIAMSD, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1136/ard.2003.017160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To identify factors associated with poor physical function in rheumatoid arthritis and to assess whether baseline joint damage has an impact on improvement in physical function during infliximab treatment. Methods: 428 patients with active rheumatoid arthritis despite methotrexate treatment received methotrexate alone or with infliximab ( 3 mg/kg or 10 mg/kg every four or eight weeks) for 54 weeks ( the ATTRACT trial). Data on clinical outcomes and physical function ( assessed by the health assessment questionnaire (HAQ)) were collected. Structural damage was assessed using the van der Heijde modification of the Sharp score. Odds ratios ( OR) for factors associated with severe functional disability (HAQ greater than or equal to 2.0) at baseline were estimated using multiple logistic regression analyses, and baseline factors related to the change in physical function after treatment at week 54 were determined. Results: Baseline radiographic scores were correlated with baseline HAQ scores. After adjustment for demographic characteristics in the logistic regression model, baseline disease activity scores, radiological joint damage, fatigue, and morning stiffness were found to be associated with severe functional disability (HAQgreater than or equal to2.0), with OR values of 2.00 (1.53 to 2.63), 1.82 (1.15 to 2.87), 1.19 (1.05 to 1.34), and 1.07 (1.01 to 1.13), respectively. In multiple linear regression analysis, physical disability, joint damage, and fatigue at baseline were correlated with less improvement in physical function after treatment. Infliximab treatment was associated with greater improvement in physical function. Conclusions: Greater joint damage at baseline was associated with poorer physical function at baseline and less improvement in physical function after treatment, underlining the importance of early intervention to slow the progression of joint destruction.
引用
收藏
页码:52 / 55
页数:4
相关论文
共 25 条
  • [1] The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications
    Bonnie Bruce
    James F Fries
    [J]. Health and Quality of Life Outcomes, 1 (1)
  • [2] Choi HK, 2001, ARTHRITIS RHEUM, V44, pS221
  • [3] Clarke AE, 2001, J RHEUMATOL, V28, P2416
  • [4] Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO
  • [5] 2-F
  • [6] Escalante A, 1999, ARTHRITIS RHEUM-US, V42, P1712, DOI 10.1002/1529-0131(199908)42:8<1712::AID-ANR21>3.0.CO
  • [7] 2-X
  • [8] GUILLEMIN F, 1992, J RHEUMATOL, V19, P366
  • [9] GUILLEMIN F, 1994, J RHEUMATOL, V21, P1051
  • [10] Kalden JR, 2002, J RHEUMATOL, V29, P27